We are live on ! Find out more
RG

Redmile Group Portfolio holdings

AUM $1.51B
1-Year Est. Return 164.17%
This Fund
S&P 500
This Quarter Est. Return
+5.19%
1 Year Est. Return
+164.17%
3 Year Est. Return
+929.47%
5 Year Est. Return
+823.75%
10 Year Est. Return
+18,826.17%
AUM
$1.3B
AUM Growth
-$24.3M
Cap. Flow
-$1.65M
Cap. Flow %
-0.13%
Top 10 Hldgs %
52.92%
Holding
72
New
14
Increased
18
Reduced
22
Closed
16

Top Buys

1
CLVS
Clovis Oncology, Inc.
CLVS
+$54.1M
2
BSX icon
Boston Scientific
BSX
+$40.3M
3
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$40.2M
4
DPLO
DIPLOMAT PHARMACY, INC.
DPLO
+$34.8M
5
ZLTQ
ZELTIQ Aesthetics, Inc.
ZLTQ
+$22.4M

Top Sells

1
RAD
Rite Aid Corporation
RAD
+$49M
2
CMRX
Chimerix, Inc.
CMRX
+$40.8M
3
BMRN icon
BioMarin Pharmaceuticals
BMRN
+$38.8M
4
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
+$33.8M
5
INCY icon
Incyte
INCY
+$28.5M

Sector Composition

1 Healthcare 79.19%
2 Communication Services 1.61%
3 Industrials 0.58%
4 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WVE icon
26
Wave Life Sciences
WVE
$1.14B
$18.3M 1.41%
+1,213,627
New +$19M
CTMX icon
27
CytomX Therapeutics
CTMX
$799M
$14.4M 1.11%
+738,356
New +$11.7M
HNT
28
DELISTED
HEALTH NET INC
HNT
$12.4M 0.96%
181,029
+1,800
+1% +$115K
ELGX
29
DELISTED
Endologix Inc
ELGX
$9.97M 0.77%
+100,718
New +$10.8M
OXFD
30
DELISTED
Oxford Immunotec Global PLC Ordinary Shares
OXFD
$9.89M 0.76%
860,288
-167,844
-16% -$2.08M
CRL icon
31
Charles River Laboratories
CRL
$11.1B
$9.84M 0.76%
+122,400
New +$8.83M
TRIV
32
DELISTED
TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK
TRIV
$9.73M 0.75%
1,462,762
-1,221
-0.1% -$8.1K
FATE icon
33
Fate Therapeutics
FATE
$347M
$7.99M 0.62%
2,371,001
+296,165
+14% +$1.24M
PGND
34
DELISTED
PRESS GANEY HOLDINGS INC COM STK (DE)
PGND
$7.56M 0.58%
239,616
+154,650
+182% +$4.93M
BPMC
35
DELISTED
Blueprint Medicines
BPMC
$7.29M 0.56%
276,687
-90,798
-25% -$2.04M
GBT
36
DELISTED
Global Blood Therapeutics, Inc.
GBT
$7.07M 0.55%
218,718
-44,174
-17% -$1.91M
DRRX
37
DELISTED
DURECT Corp
DRRX
$5.81M 0.45%
262,842
+1,510
+0.6% +$32.7K
NVTA
38
DELISTED
Invitae Corporation
NVTA
$5.42M 0.42%
660,129
– –
CASC
39
DELISTED
Cascadian Therapeutics, Inc.
CASC
$5.17M 0.4%
388,550
-213,948
-36% -$3.68M
PRQR icon
40
ProQR Therapeutics
PRQR
$244M
$4.84M 0.37%
557,193
-103,623
-16% -$1.19M
PFE icon
41
Pfizer
PFE
$141B
$4M 0.31%
+130,485
New +$4.1M
CARM
42
DELISTED
Carisma Therapeutics
CARM
$2.64M 0.2%
43,793
+1,375
+3% +$78.1K
CFMS
43
DELISTED
Conformis, Inc. Common Stock
CFMS
$2.17M 0.17%
5,028
-22,526
-82% -$11.3M
CELG
44
DELISTED
Celgene Corp
CELG
$1.2M 0.09%
+10,055
New +$1.16M
IHF icon
45
iShares US Healthcare Providers ETF
IHF
$1.19B
$562K 0.04%
+22,600
New +$561K
CCXI
46
DELISTED
ChemoCentryx, Inc.
CCXI
$512K 0.04%
63,189
-437,426
-87% -$3.1M
SRRA
47
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$373K 0.03%
620
+160
+35% +$108K
LAB icon
48
Standard BioTools
LAB
$332M
$352K 0.03%
32,561
+7,978
+32% +$78.3K
XBI icon
49
State Street SPDR S&P Biotech ETF
XBI
$10.5B
$317K 0.02%
4,530
-4,720
-51% -$322K
KDNY
50
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
$294K 0.02%
2,087
-1,124
-35% -$153K
1
2
3

Similar funds

ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
GAI
General American Investors New York $1.51B AUM 37.94% 1-Year Est. Return
HCMG
Howard Capital Management Group Los Angeles, California $1.51B AUM 21.57% 1-Year Est. Return
FMI
F/M Investments Washington, District of Columbia $1.51B AUM 25.86% 1-Year Est. Return
FCM
Fairholme Capital Management South Miami, Florida $1.51B AUM 28.27% 1-Year Est. Return
PP
PDS Planning Dublin, Ohio $1.52B AUM 18.08% 1-Year Est. Return
AM
Ares Management Los Angeles, California $1.52B AUM 12.97% 1-Year Est. Return
BFO
Boston Family Office Boston, Massachusetts $1.5B AUM 11.68% 1-Year Est. Return